UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007345 |
|---|---|
| Receipt number | R000008650 |
| Scientific Title | A phase 2 study of mid-term compliance and effectiveness of dasatinib therapy in patients with chronic myeloid leukemia. |
| Date of disclosure of the study information | 2012/03/01 |
| Last modified on | 2016/02/21 18:09:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/02/21 17:25:26 | ||
| 2 | Update | 2014/03/21 16:47:43 | Recruitment status Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 3 | Update | 2015/08/21 22:27:58 | Email |
|
| 4 | Update | 2016/02/21 18:09:08 | Recruitment status Publication of results Results |
